Metabolic syndrome-related conditions among people with and without gout: prevalence and resource use^*

References

• Wallace KL, Riedel AA, Joseph-Ridge N, et al. Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population. J Rheumatol 2004;31: 1582–7
   Google Scholar
• Saag KG, Choi H. Epidemiology, risk factors, and lifestyle modifications for gout. Arthritis Res Ther 2006;8:S2 [Epub ahead of print 12 Apr 2006]
   Google Scholar
• Suresh E. Diagnosis and management of gout: a rational approach. Postgrad Med J 2005;81:572–9
   PubMed Web of Science ®Google Scholar
• Campion EW, Glynn RJ, DeLabry LO. Asymptomatic hyper-uricemia. Risks and consequences in the Normative Aging Study. Am J Med 1987;82:421–6
   Google Scholar
• Luk AJ, Simkin PA. Epidemiology of hyperuricemia and gout. Am J Manag Care 2005;11:S435–42
   PubMed Web of Science ®Google Scholar
• Kramer HM, Curhan G. The association between gout and nephrolithiasis: the National Health and Nutrition Examination Survey III, 1988–1994. Am J Kidney Dis 2002;40:37–42
   PubMed Web of Science ®Google Scholar
• Choi HK, Atkinson K, Karlson EW, et al. Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med 2005;165:742–8
   PubMed Web of Science ®Google Scholar
• Modan M, Halkin H, Karasik A, et al. Elevated serum uric acid – a facet of hyperinsulinaemia. Diabetologia 1987;30:713–8
   PubMed Web of Science ®Google Scholar
• Chou P, Li CL, Wu GS, et al. Progression to type 2 diabetes among high-risk groups in Kin-Chen, Kinmen. Exploring the natural history of type 2 diabetes. Diabetes Care 1998;21: 1183–7
   PubMed Web of Science ®Google Scholar
• Lin KC, Tsai ST, Lin HY, et al. Different progressions of hyper-glycemia and diabetes among hyperuricemic men and women in the Kinmen study. J Rheumatol 2004;31:1159–65
   PubMed Web of Science ®Google Scholar
• Nakanishi N, Okamoto M, Yoshida H, et al. Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers. Eur J Epidemiol 2003;18:523–30
   PubMed Web of Science ®Google Scholar
• Jossa F, Farinaro E, Panico S et al. Serum uric acid and hyper-tension: the Olivetti heart study. J Hum Hypertens 1994;8: 677–81
   PubMed Web of Science ®Google Scholar
• Masuo K, Kawaguchi H, Mikami H, et al. Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 2003;42:474–80
   PubMed Web of Science ®Google Scholar
• Feig DI, Johnson RJ. Hyperuricemia in childhood primary hyper-tension. Hypertension 2003;42:247–52
   PubMed Web of Science ®Google Scholar
• Rathmann W, Funkhouser E, Dyer AR, et al. Relations of hyper-uricemia with the various components of the insulin resistance syndrome in young black and white adults: the CARDIA study. Coronary Artery Risk Development in Young Adults. Ann Epidemiol 1998;8:250–61
   PubMed Web of Science ®Google Scholar
• Johnson RJ, Segal MS, Srinivas T, et al. Essential hypertension, progressive renal disease, and uric acid: a pathogenetic link? J Am Soc Nephrol 2005;16:1909–19
   PubMed Web of Science ®Google Scholar
• Choi HK, Curhan G. Gout: epidemiology and lifestyle choices. Curr Opin Rheumatol 2005;17:341–5
   PubMed Web of Science ®Google Scholar
• Vazquez-Mellado J, Alvarez Hernandez E, Burgos-Vargas R. Primary prevention in rheumatology: the importance of hyper-uricemia. Best Pract Res Clin Rheumatol 2004;18:111–24
   PubMed Web of Science ®Google Scholar
• Bieber JD, Terkeltaub RA. Gout: on the brink of novel therapeutic options for an ancient disease. Arthritis Rheum 2004;50:2400–14
   PubMed Web of Science ®Google Scholar
• Fam AG. Gout, diet, and the insulin resistance syndrome. J Rheumatol 2002;29:1350–5
   PubMed Web of Science ®Google Scholar
• Emmerson B. Hyperlipidaemia in hyperuricaemia and gout. Ann Rheum Dis 1998;57:509–10
   PubMed Web of Science ®Google Scholar
• Solymoss BC, Marcil M, Chaour M, et al. Fasting hyperinsulinism, insulin resistance syndrome, and coronary artery disease in men and women. Am J Cardiol 1995;76:1152–6
   PubMed Web of Science ®Google Scholar
• American Heart Association; National Heart, Lung, and Blood Institute; Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. Cardiol Rev 2005;13:322–7
   Google Scholar
• Grundy SM, Hansen B, Smith SC Jr, et al. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Arterioscler Thromb Vasc Biol 2004;24: e19–24
   PubMed Web of Science ®Google Scholar
• Kahn R, Buse J, Ferrannini E, et al. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005;28:2289–4
   PubMed Web of Science ®Google Scholar
• Shah S, Novak S, Stapleton LM. Evaluation and comparison of models of metabolic syndrome using confirmatory factor analysis. Eur J Epidemiol 2006;21:343–9
   Google Scholar
• Niskanen LK, Laaksonen DE, Nyyssonen K, et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 2004;164:1546–51
   PubMed Web of Science ®Google Scholar
• Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971– 1992. National Health and Nutrition Examination Survey. JAMA 2000;283:2404–10
   Google Scholar
• Baker JF, Krishnan E, Chen L, et al. Serum uric acid and cardiovascular disease: recent developments, and where do they leave us? Am J Med 2005;118:816–26
   PubMed Web of Science ®Google Scholar
• Krishnan E, Baker JF, Furst DE, et al. Gout and the risk of acute myocardial infarction. Arthritis Rheum 2006;54:2688–96
   PubMed Web of Science ®Google Scholar
• Doehner W, Schoene N, Rauchhaus M, et al. Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies. Circulation 2002;105:2619–24
   PubMed Web of Science ®Google Scholar
• Anker SD, Doehner W, Rauchhaus M, et al. Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation 2003;107:1991–7
   PubMed Web of Science ®Google Scholar
• Riedel AA, Nelson M, Wallace K, et al. Prevalence of comorbid conditions and prescription medication use among patients with gout and hyperuricemia in a managed care setting. J Clin Rheumatol 2004;10:308–14
   PubMed Web of Science ®Google Scholar
• Elixhauser A, Steiner C, Palmer L. Clinical Classifications Software, 2004. U.S. Agency for Healthcare and Research. Available from http://www.hcup-us.ahrq.gov/toolssoftware/%20ccs/ccs.jsp [Last accessed November 4, 2004]
   Google Scholar
• Kraja AT, Borecki IB, North K, et al. Longitudinal and age trends of metabolic syndrome and its risk factors: The Family Heart Study. Nutr Metab (Lond) 2006;3:41
   PubMed Web of Science ®Google Scholar
• Freedman DS, Williamson DF, Gunter EW, et al. Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-up Study. Am J Epidemiol 1995;141:637–44
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Schillaci G, Reboldi G, et al. Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study. Hypertension 2000;36: 1072–8
   PubMed Web of Science ®Google Scholar
• Becker MA, Jolly M. Hyperuricemia and associated diseases. Rheum Dis Clin North Am 2006;32:275–93
   PubMed Web of Science ®Google Scholar
• Rao JK, Callahan LF, Helmick CG 3rd. Characteristics of persons with self-reported arthritis and other rheumatic conditions who do not see a doctor. J Rheumatol 1997;24:169–73
   Google Scholar